Sauvage Philippe sold $286K of NUVB
Sauvage Philippe (Chief Financial Officer) sold 47,668 shares of Nuvation Bio Inc. (NUVB) at $6.01 ($0.29M total) on 2026-06-23 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider activity record (shares sold, price, post-transaction holdings) but does not provide new operating or financial guidance.
Market read
Traders may monitor for follow-on insider activity, but this single 10b5-1 sale is usually not a standalone trading catalyst.
What to watch
The filing does not disclose reasons for the sale; traders should avoid inferring directionality without corroborating operational or guidance news.
Background
The article is an SEC Form 4 insider transaction for Nuvation Bio, reported by the CFO.
Ticker impact
Nuvation Bio CFO Sauvage Philippe sold 47,668 shares in an open-market transaction at $6.0076/share under a 10b5-1 plan.
Likely limited near-term impact; any reaction should be small and short-lived unless paired with other new company news.
Form 4 provides a concrete datapoint (size, price, 10b5-1), but insider sales—especially under pre-arranged plans—are typically not a standalone catalyst.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerNUVATION BIO INC.
Company whose CFO reported an open-market sale of shares via a 10b5-1 plan.
- insiderSauvage Philippe
Chief Financial Officer who sold 47,668 shares at $6.0076/share.
